clinical trial · NCT06954766
Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981
Knee OsteoarthritisCKD-981(1)CKD-981(2)Sham deviceReference DrugPlacebo Drug
brief summary
The purpose of this study is to prove that the temporary symptom improvement effect on knee osteoarthritis using CKD-981
started
Apr 28, 2025
primary completion
Oct 28, 2025
completion
Oct 28, 2025
last updated
Apr 13, 2026
detailed description
The aim of this pilot study is to evaluate the efficacy and safety of CKD-981 in patients with mild to moderate degenerative knee osteoarthritis who have been experiencing pain more than 8 weeks
official title
A Randomized, Double-blind, Sham-controlled, Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981 in Patients With Degenerative Knee Osteoarthritis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol